VoxCell BioInnovation
Creating complex 3d bioprinted models, specifically in the area of tissue engineering and the drug development industry.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | $1.0m | Grant | |
| Total Funding | 000k | ||
Related Content
VoxCell BioInnovation is a biotechnology company that has developed a method for creating 3D vascularized cancer tissue models for in-vitro drug testing. The company's platform aims to reduce the dependency on animal testing and enhance the accuracy of preclinical drug screening.
By employing high-resolution bioprinting, proprietary vascularization software, and specialized bioinks, VoxCell constructs human-like tumor models that replicate the tumor microenvironment. These models are designed for use in the drug development industry and oncology research, providing a more realistic platform for evaluating drug efficacy and distribution. The company offers a service to screen candidate compounds in these tissue models, delivering translatable data to its clients.
VoxCell's business model is centered on providing these advanced testing solutions as a service to pharmaceutical and biotechnology companies. The company also sells biopolymers and photoinitiators for tissue engineering and 3D cell culture applications.
Keywords: 3D bioprinting, vascularized tissue models, cancer research, drug development, preclinical testing, in-vitro models, tissue engineering, oncology, biopolymers, photoinitiators